Orasis Pharmaceuticals raised $78 million in a Series D round led by Arboretum Ventures and Johnson & Johnson Innovation to support the commercial launch of Qlosi, a novel corrective eye drop for the treatment of presbyopia.
Amount Raised
$78 Million
Round Type
Series D
Ponte Vedra BeachBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Orasis Pharmaceuticals announced a $78 million Series D funding round to support the launch of Qlosi, an eye drop designed for presbyopia treatment. The funding included a $68 million equity component and $15 million in structured capital. The investment was backed by notable firms including Arboretum Ventures, Johnson & Johnson Innovation, and several returning investors.
Quick answer
Orasis Pharmaceuticals raised $78 Million in a Series D round, dated October 10, 2024. Investors: Johnson & Johnson Innovation – Jjdc, Inc., Johnson & Johnson Innovation – JJDC, Catalio Capital Management, Freepoint Capital Group, Visionary Ventures, Bluestem Capital, Sbi (Japan) Innovation Fund and Sequoia Capital. Orasis Pharmaceuticals is based in Ponte Vedra Beach, Florida, United States.
- How much did Orasis Pharmaceuticals raise?
- Orasis Pharmaceuticals raised $78 Million in a Series D round on October 10, 2024.
- Who invested in Orasis Pharmaceuticals?
- Johnson & Johnson Innovation – Jjdc, Inc., Johnson & Johnson Innovation – JJDC, Catalio Capital Management, Freepoint Capital Group, Visionary Ventures, Bluestem Capital, Sbi (Japan) Innovation Fund and Sequoia Capital are named as investors in this round.
- What does Orasis Pharmaceuticals do?
- Orasis Pharmaceuticals developed Qlosi, a corrective eye drop for the treatment of presbyopia in adults.
- Where is Orasis Pharmaceuticals based and how big is it?
- Orasis Pharmaceuticals is based in Ponte Vedra Beach, Florida, United States. Fundz records about 32 employees.
- Who are the decision-makers at Orasis Pharmaceuticals?
- Fundz holds 4 contacts at Orasis Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Orasis Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $4.2M (Seed) on November 21, 2024.
- Qnovia raised $14M on October 29, 2024.
- Pathos AI raised $62M (Series C) on October 29, 2024.
- Pathos AI raised $62M on October 24, 2024.
- Ensho Therapeutics raised $5M on October 24, 2024.
- Cumulus Oncology raised $50M (Series A) on September 3, 2024.
Who to call at Orasis Pharmaceuticals, and when
A new round usually means Orasis Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orasis Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orasis Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orasis Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orasis Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Orasis Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.